Projects funded by the NCN

First-in-class dual modulators of necroptosis kinases and 5-HT6 receptors as an innovative approach to develop an effect...

Call: OPUS 26 , Panel: NZ7

Principal investigator: prof. Jadwiga Handzlik

Uniwersytet Jagielloński, Collegium Medicum

(Micro)RNA and informatics approaches for diagnosis, prognosis and treatment of Alzheimer's disease and Dementia

Call: JPND Call 2023 , Panel: NZ3

Principal investigator: dr hab. Agnieszka Fiszer

Instytut Chemii Bioorganicznej PAN

Search for novel IKK-β inhibitors in the context of diseases with neuroinflammatory origin – structure-based drug design...

Call: PRELUDIUM 22 , Panel: NZ7

Principal investigator: Emilia Aleksandra Sługocka

Uniwersytet Jagielloński, Collegium Medicum

Crystallographic analysis of RNA-ligand complexes. Towards rational design oflead compounds for development of therapies...

Call: OPUS 23 , Panel: NZ7

Principal investigator: dr hab. Agnieszka Ludmiła Kiliszek

Instytut Chemii Bioorganicznej PAN

Psychedelics as Therapeutic Candidates in Neurodegenerative Disorders Treatment– a Study in Spinocerebellar Ataxia Type ...

Call: SONATINA 5 , Panel: NZ4

Principal investigator: dr Urszula Joanna Kozłowska

Instytut Chemii Bioorganicznej PAN

Physical exercise as a natural mechanism inducing neuroregeneration. Search for the new protein markers and therapeutic ...

Call: OPUS 18 , Panel: NZ7

Principal investigator: dr hab. Katarzyna Zofia Kuter-Nowak

Instytut Farmakologii PAN

Oligomer-Focused Screening and Individualized Therapeutics to target Neurodegenerative Disorders

Call: JPND2019 , Panel: NZ1

Principal investigator: dr Piotr Hańczyc

Uniwersytet Warszawski, Wydział Fizyki

Nanomolecular antioxidants: biological basis of targeted therapy of neurodegenerative diseases.

Call: SONATA BIS 6 , Panel: NZ7

Principal investigator: dr hab. Izabela Anna Sadowska-Bartosz

Uniwersytet Rzeszowski, Kolegium Nauk Przyrodniczych

Search for the functionally selective 5-HT1A receptor agonists as new pharmacological tools in the development of treatm...

Call: OPUS 10 , Panel: NZ7

Principal investigator: prof. Marcin Roman Kołaczkowski

Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny